AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LOTEPREDNOL ETABONATE

10 registrations across 5 African markets— 8 active

Markets with LOTEPREDNOL ETABONATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Lotel Gel
Ophthalmic Solution
🇰🇪KenyaAjanta Pharma LimitedactiveFeb 2028
LOTEMAX 0,5% SUSPENSION OPHTALMIQUE FLACON DE 5ML🇨🇮Côte d'IvoireLABORATOIRES BAUSCH&LOMB INCORPORATEDexpiredFeb 2024
LOTEMAX 0,5% GEL OPHTALMIQUE FLACON DE 10ML🇨🇮Côte d'IvoireLABORATOIRES BAUSCH&LOMB INCORPORATEDexpiredFeb 2024
LOTEMAX OPHTHALMIC GEL🇿🇦South AfricaSoflens (Pty) LtdactiveJan 1900
LOTEMAX CO🇿🇦South AfricaSoflens (Pty) LtdactiveJan 1900
ALREX🇿🇦South AfricaSoflens (Pty) LtdactiveJan 1900
LOTEMAX OPHTHALMIC SUSPENSION🇿🇦South AfricaSoflens (Pty) LtdactiveJan 1900
Lotel gel
Ophthalmic Ointment
🇹🇿TanzaniaAjanta Pharma Limitedactive
LOTEPREDNOL ETABONATE
OPHTHALMIC GELS/SOLS
🇺🇬UgandaAJANTA PHARMA LIMTEDactive
LOTEPREDNOL ETABONATE
OPHTHALMIC GELS/SOLS
🇺🇬UgandaAJANTA PHARMA LIMTEDactive

LOTEPREDNOL ETABONATE in Africa — Regulatory Overview

LOTEPREDNOL ETABONATE is registered across 5 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Côte d'Ivoire, Uganda, Kenya and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.